JP2006503806A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006503806A5 JP2006503806A5 JP2004508780A JP2004508780A JP2006503806A5 JP 2006503806 A5 JP2006503806 A5 JP 2006503806A5 JP 2004508780 A JP2004508780 A JP 2004508780A JP 2004508780 A JP2004508780 A JP 2004508780A JP 2006503806 A5 JP2006503806 A5 JP 2006503806A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical preparation
- preparation according
- active substance
- ion exchanger
- substance bound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000825 pharmaceutical preparation Substances 0.000 claims 5
- 239000013543 active substance Substances 0.000 claims 4
- 239000003795 chemical substances by application Substances 0.000 claims 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims 2
- 238000005342 ion exchange Methods 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 claims 1
- SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 1
- KYGZCKSPAKDVKC-UHFFFAOYSA-N Oxolinic acid Chemical group C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC2=C1OCO2 KYGZCKSPAKDVKC-UHFFFAOYSA-N 0.000 claims 1
- 229920002125 Sokalan® Polymers 0.000 claims 1
- 239000000440 bentonite Substances 0.000 claims 1
- 229910000278 bentonite Inorganic materials 0.000 claims 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 claims 1
- 229920003086 cellulose ether Polymers 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229960000740 enrofloxacin Drugs 0.000 claims 1
- 239000006194 liquid suspension Substances 0.000 claims 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 1
- 239000008108 microcrystalline cellulose Substances 0.000 claims 1
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000004584 polyacrylic acid Substances 0.000 claims 1
- 229960001248 pradofloxacin Drugs 0.000 claims 1
- LZLXHGFNOWILIY-APPDUMDISA-N pradofloxacin Chemical group C12=C(C#N)C(N3C[C@H]4NCCC[C@H]4C3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 LZLXHGFNOWILIY-APPDUMDISA-N 0.000 claims 1
- 239000003306 quinoline derived antiinfective agent Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229920001285 xanthan gum Polymers 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10224086A DE10224086A1 (de) | 2002-05-31 | 2002-05-31 | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| DE10224086.8 | 2002-05-31 | ||
| PCT/EP2003/005228 WO2003101422A2 (de) | 2002-05-31 | 2003-05-19 | Pharmazeutiche zubereitungen zur oralen anwendung enthaltend wirkstoffbeladene ionentauscherharze sowie strukturviskose gelbildner als verdicker |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010235021A Division JP2011012087A (ja) | 2002-05-31 | 2010-10-20 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2006503806A JP2006503806A (ja) | 2006-02-02 |
| JP2006503806A5 true JP2006503806A5 (enExample) | 2006-07-06 |
| JP5350574B2 JP5350574B2 (ja) | 2013-11-27 |
Family
ID=29432468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004508780A Expired - Lifetime JP5350574B2 (ja) | 2002-05-31 | 2003-05-19 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
| JP2010235021A Withdrawn JP2011012087A (ja) | 2002-05-31 | 2010-10-20 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010235021A Withdrawn JP2011012087A (ja) | 2002-05-31 | 2010-10-20 | 活性物質を担持するイオン交換樹脂および増粘剤として本質的に粘性のあるゲル化剤を含む経口医薬製剤 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US8545829B2 (enExample) |
| EP (1) | EP1513500B1 (enExample) |
| JP (2) | JP5350574B2 (enExample) |
| KR (3) | KR101258373B1 (enExample) |
| CN (1) | CN1671361B (enExample) |
| AR (2) | AR039861A1 (enExample) |
| AT (1) | ATE421317T1 (enExample) |
| AU (1) | AU2003242545B2 (enExample) |
| BR (2) | BRPI0311511B1 (enExample) |
| CA (1) | CA2487648C (enExample) |
| CR (1) | CR7598A (enExample) |
| DE (2) | DE10224086A1 (enExample) |
| DK (1) | DK1513500T3 (enExample) |
| ES (1) | ES2319115T3 (enExample) |
| HR (1) | HRP20041219B1 (enExample) |
| IL (2) | IL165322A0 (enExample) |
| MX (1) | MXPA04011820A (enExample) |
| MY (1) | MY140953A (enExample) |
| NO (1) | NO333939B1 (enExample) |
| PL (1) | PL207269B1 (enExample) |
| PT (1) | PT1513500E (enExample) |
| RU (1) | RU2380091C2 (enExample) |
| SI (1) | SI1513500T1 (enExample) |
| TW (1) | TWI333422B (enExample) |
| UA (1) | UA84270C2 (enExample) |
| WO (1) | WO2003101422A2 (enExample) |
| ZA (1) | ZA200409616B (enExample) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102004001558A1 (de) * | 2004-01-10 | 2005-08-18 | Bayer Healthcare Ag | Arzneimittel zur topischen Applikation bei Tieren |
| US20080095842A1 (en) * | 2004-12-06 | 2008-04-24 | Antarkar Amit K | Rapidly Disintegrating Taste Masked Compositions and a Process for Its Preparations |
| DE102005025900A1 (de) * | 2005-06-06 | 2006-12-07 | Basf Ag | Verfahren zur Entfernung von Salzen aus einem Alkoxycarbonylaminotriazin enthaltenden Reaktionsgemisch |
| US20080051332A1 (en) * | 2005-11-18 | 2008-02-28 | Nastech Pharmaceutical Company Inc. | Method of modulating hematopoietic stem cells and treating hematologic diseases using intranasal parathyroid hormone |
| CN100360131C (zh) * | 2006-01-24 | 2008-01-09 | 新昌国邦化学工业有限公司 | 一种掩味恩诺沙星的生产方法 |
| US20070248564A1 (en) * | 2006-04-25 | 2007-10-25 | Roxane Laboratories, Inc. | Formulation of sodium polystyrene sulfonate suspension for the treatment of hyperkalemia |
| CA2661576A1 (en) * | 2006-09-26 | 2008-04-03 | Taro Pharmaceuticals North America, Inc. | Stabilizing compositions for antibiotics and methods of use |
| DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| US20080118570A1 (en) * | 2006-11-20 | 2008-05-22 | Zhi Liu | Polymer coated drug-ion exchange resins and methods |
| EP2262536A4 (en) * | 2008-03-26 | 2013-07-03 | Taro Pharmaceuticals North America Inc | STABILIZING LIPID COMPOSITIONS FOR ORAL PHARMACEUTICAL AGENTS |
| AU2011226523C1 (en) | 2010-03-12 | 2016-07-14 | Monsanto Technology Llc | Agrochemical gel compositions |
| ES2588008T3 (es) * | 2010-05-19 | 2016-10-28 | Astellas Pharma Inc. | Composición farmacéutica que contiene solifenacina |
| AU2012326513B2 (en) | 2011-10-19 | 2016-03-17 | R.P. Scherer Technologies, Llc | Two phase pharmaceutical delivery system |
| FR2998305B1 (fr) * | 2012-11-22 | 2015-02-20 | Henkel Ag & Co Kgaa | Substances actives contenant des groupes sulfonates ameliorant la puissance de lavage primaire |
| KR101697095B1 (ko) * | 2015-09-30 | 2017-01-18 | 주식회사 포스코 | 더스트 막힘을 방지할 수 있는 배가스 청정 라인의 실탱크 |
| CN111989314B (zh) | 2018-04-25 | 2024-04-30 | 拜耳动物保健有限责任公司 | 喹诺酮甲酸酯水解的方法 |
| CN114249749B (zh) * | 2022-01-08 | 2024-03-22 | 天象生物药业邢台有限责任公司 | 一种马波沙星甲酸盐的转化方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US614622A (en) * | 1898-11-22 | Machine for making billets | ||
| JPS60204713A (ja) * | 1984-03-30 | 1985-10-16 | Zenyaku Kogyo Kk | 水性懸濁組成物 |
| GB8618847D0 (en) | 1986-08-01 | 1986-09-10 | Smith Kline French Lab | Pharmaceutical formulations |
| DE3719764A1 (de) * | 1987-06-13 | 1988-12-22 | Bayer Ag | Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung |
| US5338732A (en) | 1991-06-18 | 1994-08-16 | Bristol-Myers Squibb Company | Megestrol acetate formulation |
| AU2884892A (en) * | 1991-10-28 | 1993-06-07 | Procter & Gamble Company, The | Beverage thickener/emulsifier system |
| JP3207494B2 (ja) * | 1992-04-02 | 2001-09-10 | ロート製薬株式会社 | 水性懸濁製剤 |
| DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
| AU715341B2 (en) * | 1996-02-23 | 2000-01-20 | Bayer Intellectual Property Gmbh | Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8- diazabicyclo-(4.3.0)-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo- 3-quinolin carboxylic acids and their derivatives |
| US5980882A (en) * | 1997-04-16 | 1999-11-09 | Medeva Pharmaceuticals Manufacturing | Drug-resin complexes stabilized by chelating agents |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| CZ302919B6 (cs) * | 1999-07-14 | 2012-01-18 | Schering-Plough Ltd. | Vodný farmaceutický prostredek |
| GB9930058D0 (en) | 1999-12-20 | 2000-02-09 | Novartis Ag | Organic compounds |
| GB0020089D0 (en) | 2000-08-15 | 2000-10-04 | Smithkline Beecham Biolog | Vaccine Composition |
| DE10134719A1 (de) * | 2001-07-17 | 2003-02-06 | Bayer Ag | Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze |
| US7001667B2 (en) * | 2002-07-17 | 2006-02-21 | Ppg Industries Ohio, Inc. | Alkyd-based free radical wood coating compositions |
-
2002
- 2002-05-31 DE DE10224086A patent/DE10224086A1/de not_active Withdrawn
-
2003
- 2003-05-19 IL IL16532203A patent/IL165322A0/xx unknown
- 2003-05-19 RU RU2004139022/15A patent/RU2380091C2/ru active
- 2003-05-19 DE DE50311123T patent/DE50311123D1/de not_active Expired - Lifetime
- 2003-05-19 ES ES03755931T patent/ES2319115T3/es not_active Expired - Lifetime
- 2003-05-19 PL PL373456A patent/PL207269B1/pl unknown
- 2003-05-19 SI SI200331534T patent/SI1513500T1/sl unknown
- 2003-05-19 UA UA20041210942A patent/UA84270C2/ru unknown
- 2003-05-19 KR KR1020117031524A patent/KR101258373B1/ko not_active Expired - Lifetime
- 2003-05-19 BR BRPI0311511-9A patent/BRPI0311511B1/pt unknown
- 2003-05-19 DK DK03755931T patent/DK1513500T3/da active
- 2003-05-19 KR KR1020127026888A patent/KR20120123607A/ko not_active Ceased
- 2003-05-19 BR BR0311511-9A patent/BR0311511A/pt active IP Right Grant
- 2003-05-19 AU AU2003242545A patent/AU2003242545B2/en not_active Expired
- 2003-05-19 HR HRP20041219AA patent/HRP20041219B1/hr not_active IP Right Cessation
- 2003-05-19 JP JP2004508780A patent/JP5350574B2/ja not_active Expired - Lifetime
- 2003-05-19 KR KR10-2004-7019371A patent/KR20050010015A/ko not_active Ceased
- 2003-05-19 PT PT03755931T patent/PT1513500E/pt unknown
- 2003-05-19 CN CN038182106A patent/CN1671361B/zh not_active Expired - Lifetime
- 2003-05-19 MX MXPA04011820A patent/MXPA04011820A/es active IP Right Grant
- 2003-05-19 WO PCT/EP2003/005228 patent/WO2003101422A2/de not_active Ceased
- 2003-05-19 CA CA2487648A patent/CA2487648C/en not_active Expired - Lifetime
- 2003-05-19 EP EP03755931A patent/EP1513500B1/de not_active Expired - Lifetime
- 2003-05-19 AT AT03755931T patent/ATE421317T1/de active
- 2003-05-19 US US10/516,344 patent/US8545829B2/en not_active Expired - Fee Related
- 2003-05-28 AR ARP030101867A patent/AR039861A1/es not_active Application Discontinuation
- 2003-05-29 MY MYPI20031984A patent/MY140953A/en unknown
- 2003-05-30 TW TW092114643A patent/TWI333422B/zh not_active IP Right Cessation
-
2004
- 2004-11-22 IL IL165322A patent/IL165322A/en active IP Right Grant
- 2004-11-24 CR CR7598A patent/CR7598A/es not_active Application Discontinuation
- 2004-11-29 ZA ZA200409616A patent/ZA200409616B/xx unknown
- 2004-12-29 NO NO20045700A patent/NO333939B1/no not_active IP Right Cessation
-
2010
- 2010-10-20 JP JP2010235021A patent/JP2011012087A/ja not_active Withdrawn
-
2016
- 2016-08-23 AR ARP160102580A patent/AR105798A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006503806A5 (enExample) | ||
| CN102083467B (zh) | 固体分散体及其药物组合物、以及它们的制备方法 | |
| ES2427252T5 (es) | Composición farmacéutica de fenofibrato que presenta una biodisponibilidad elevada y procedimiento de preparación | |
| RU2004139022A (ru) | Фармацевтические препараты для орального употребления, содержащие заполненные биологически активными веществами ионообменные смолы, а также структурно-вязкие агенты гелеобразования в качестве загустителей | |
| ES2390879T3 (es) | Formulaciones de atomoxetina | |
| CN100562317C (zh) | 含大量酸不稳定药物的颗粒 | |
| JPS62123112A (ja) | 軟膏基剤 | |
| JP2009545560A5 (enExample) | ||
| RU2009141538A (ru) | Твердые лекарственные формы, содержащие тадалафил | |
| KR20010062478A (ko) | 경구투여후 트리메트아지딘의 지속적 방출을 가능케 하는매트릭스 정제 | |
| ES2750323T3 (es) | Método para la fabricación de un comprimido mediante radiofrecuencia y partículas recubiertas con pérdida | |
| CA2503361A1 (en) | Controlled-release compositions | |
| JP2006514967A5 (enExample) | ||
| CN103006612B (zh) | 一种赖诺普利迟释缓释片剂及其制备方法 | |
| CN103284962B (zh) | 莫西沙星分散片及制备方法 | |
| JP2012529431A (ja) | トロンビン受容体アンタゴニストおよびクロピドグレルの固定用量錠剤 | |
| JP2011516544A5 (enExample) | ||
| EP2393486A1 (en) | Aceclofenac-containing controlled-release oral drug preparations and their manufacturing process | |
| CN106794142A (zh) | 核心组合物 | |
| JP5721093B2 (ja) | 崩壊錠 | |
| WO2014111799A1 (es) | Composición de difenidol de liberación prolongada | |
| TW201212953A (en) | Coating agent for solid pharmaceutical preparation, film coating preparation for pharmaceutical use and coated solid pharmaceutical preparation | |
| JP2005500332A5 (enExample) | ||
| JP2003518486A5 (enExample) | ||
| CN101612152A (zh) | 一种含有匹多莫德的药物组合物及其制备方法 |